- Stock declined 5.10% to ₹646.90 with a bearish candle formation
- December quarter net profit stood at ₹5,190 lakh on income of ₹1,00,290 lakh
- Price moved near 21-day SMA around ₹651.41, indicating loss of short-term strength
Overview
Krishna Institute of Medical Sciences Limited (NSE: KIMS) witnessed a sharp decline of over 5% to ₹646.90, reversing part of its recent recovery. The stock had shown a steady bounce from lower levels earlier, but the latest move suggests hesitation near higher zones.
The decline indicates a shift in near-term sentiment, with price action pointing toward profit booking after the recent up move.
Fundamental View
For the quarter ended December 2025, the company reported consolidated total income of ₹1,00,290 lakh. Profit before tax stood at ₹6,860 lakh, while net profit came in at ₹5,190 lakh, translating into an EPS of ₹1.33.
KIMS continues to benefit from its hospital network and steady healthcare demand. The overall business remains structurally stable, although valuation metrics remain relatively elevated, which can influence short-term stock reactions.
Technical View
KIMS is currently trading near ₹646.90 and has slipped toward its 21-day SMA positioned around ₹651.41. The stock has formed a bearish candle after failing to sustain higher levels, indicating rejection near the upper band.
The recent bounce appears to be losing momentum, with the price structure showing signs of consolidation turning into a mild corrective phase. While the broader trend is not fully broken, near-term strength has weakened.
RSI is hovering in the mid-range and trending lower, reflecting cooling momentum after the recent rise. This suggests the stock may continue to face pressure in the short term unless it stabilizes quickly.
Key Technical Levels
The stock is approaching a support zone in the ₹620–₹600 range, which could act as a near-term cushion if weakness continues. A break below this band may open room for further downside. On the upside, resistance is likely in the ₹680–₹720 zone, where recovery attempts could face selling pressure.
Source: TradingView
Risks To Watch
- Sustained weakness below short-term moving averages
- Profit booking after recent rebound
- Elevated valuation multiples
- Any slowdown in hospital occupancy or margins
Summary
Krishna Institute of Medical Sciences has seen a notable pullback after a recent recovery phase, indicating that near-term momentum is softening. While the company’s fundamentals remain steady, the technical setup suggests a pause or mild correction.
The stock now needs to hold above its support zone to avoid further downside. Any meaningful recovery will depend on its ability to regain strength above resistance levels and sustain momentum.
FAQs
Why did KIMS stock fall today?
The decline appears to be driven by profit booking after a recent bounce and resistance near higher levels.
What are the key levels to watch?
Support is placed at ₹620–₹600, while resistance is seen at ₹680–₹720.
Is the long-term outlook still positive?
Yes, fundamentals remain stable, but short-term momentum has weakened.